Inverted Yoga and Near Syncope: An Unusual Diagnosis of Right Ventricular Myxoma

Autor: Wadie David, Narmeen Rehman, Robby Singh, Shukri David

Publikováno v: Case Reports in Cardiology, Vol 2018 (2018)

Primary cardiac tumors are extremely rare and are difficult to diagnose. Although usually benign in nature, myxomas require surgical resection due to their increased risk of embolic and cardiac complications, with the timing of resection dependent on

Externí odkaz: https://doaj.org/article/cc5e8dd256a240fa97ebdf3038a384da

Myocardial Infarction in a Young Female with Palindromic Rheumatism: A Consequence of Negative Remodeling

Autor: Timothy R. Larsen, Sachin Kumar Amruthlal Jain, Jamal Zarghami, Shukri David

Publikováno v: Case Reports in Medicine, Vol 2012 (2012)

Palindromic rheumatism is a rare disease associated with systemic inflammation. Negative or constrictive coronary artery remodeling is typically not seen until the 7th or 8th decade of life. We report a case of a young female with palindromic rheumat

Externí odkaz: https://doaj.org/article/0004829ba6204a73b52577e6a0f8f0c4

Is Race a Risk Factor for the Development of Renal Artery Stenosis?

Autor: Ayad Jazrawi, Saba Darda, Peter Burke, Marcos Daccarett, Josef Stehlik, Shukri David, Marcel Zughaib

Publikováno v: Cardiology Research and Practice, Vol 2009 (2009)

Externí odkaz: https://doaj.org/article/74f1ce0c8caf4103ae73b644b6181113

Long-term outcomes after catheter-based renal artery denervation for resistant hypertension: final follow-up of the randomised SYMPLICITY HTN-3 Trial

Autor: Deepak L Bhatt, Muthiah Vaduganathan, David E Kandzari, Martin B Leon, Krishna Rocha-Singh, Raymond R Townsend, Barry T Katzen, Suzanne Oparil, Sandeep Brar, Vanessa DeBruin, Martin Fahy, George L Bakris, George Bakris, Sidney A Cohen, Ralph D'Agostino, Murray Esler, John Flack, Barry Katzen, Martin Leon, Laura Mauri, Manuela Negoita, Ray Townsend, Ziad Abbud, Tayo Addo, David Anderson, John Angle, Herbert Aronow, Anvar Babaev, Keith Benzuly, Somjot Brar, David Brown, David Calhoun, Paul Casale, Sheldon Chaffer, James Choi, Eugene Chung, Debbie L Cohen, Mark Creager, George Dangas, Harold Dauerman, Shukri David, Mark Davies, Eduardo de Marchena, Ali E Denktas, Chandan Devireddy, William Downey, Mark Dunlap, Daniel Fisher, Magdi Ghali, Eric Gnall, Raghava Gollapudi, Mark Goodwin, Nilesh Goswami, Luis Gruberg, Rajiv Gulati, Anuj Gupta, Anjan Gupta, Hitinder Gurm, Jeffrey Hastings, Scott Kinlay, Robert Kipperman, Maurice Buchbinder, Ajay Kirtane, Richard Kovach, David Lee, Samuel Mann, Steven Marso, Fadi Matar, Ernest Mazzaferri, Farrel Mandelsohn, Issam Moussa, Timothy Murphy, Sandeep Nathan, Brian Negus, Sahil Parikh, Manesh Patel, Kirikumar Patel, Basil Paulus, George Petrossian, Alex Powell, Jacek Preibisz, Florian Rader, Otelio Randall, Mahmood Razavi, John Reilly, Jonathan Reiner, Michael Ring, Mark Robbins, Kevin Rogers, Nicolas Ruggiero, Renato Santos, William Little, John Schindler, Thomas Scott, Thomas Shimshak, Mehdi Shishehbor, Mitchel Silver, Jasvindar Singh, Kanwar Singh, David Slovut, Rick G Stoufer, Paul Teirsten, Thomas Todoran, George Vetrovec, Ron Waksman, Yale Wang, Sergio Waxman, Robert Wilkins, Khaled Ziada, Frank Zidar

Publikováno v: The Lancet. 400:1405-1416

The SYMPLICITY HTN-3 (Renal Denervation in Patients With Uncontrolled Hypertension) trial showed the safety but not efficacy of the Symplicity system (Medtronic, Santa Rosa, CA, USA) at 6 months follow-up in patients with treatment-resistant hyperten

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6a981fbef2ed54ff03de9cebab9ff765
https://doi.org/10.1016/s0140-6736(22)01787-1

One‐year outcomes of supersaturated oxygen therapy in acute anterior myocardial infarction: The IC‐HOT study

Autor: Amir Lotfi, Hal S. Wasserman, M. Ozgu Ozan, Zubair Khan, Ivan Hanson, D. Christopher Metzger, Shmuel Chen, Philippe Généreux, Akiko Maehara, Simon R. Dixon, Shukri David, Thomas A. LaLonde, Gregg W. Stone

Publikováno v: Catheterization and Cardiovascular Interventions. 97:1120-1126

Background Supersaturated oxygen (SSO2 ) has recently been approved by the U.S. Food and Drug Administration for administration after primary percutaneous coronary intervention (pPCI) in patients with anterior ST-segment elevation myocardial infarcti

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e7912a3542a51817b74de67d1d1fb73f
https://doi.org/10.1002/ccd.29090